|
CAD HCP Survey |
Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with rare blood disorders, including cold agglutinin disease (CAD).
We would like to request your participation in a market research survey on CAD which will help us in understanding the unmet needs for patients with CAD. Your insights will be of great value to improve our offerings to you and your patients.
Please take a moment to complete our 3-question survey below.
We would like to request your participation in a market research survey on CAD which will help us in understanding the unmet needs for patients with CAD. Your insights will be of great value to improve our offerings to you and your patients.
Please take a moment to complete our 3-question survey below.